Thrombotic Microangiopathy: Long Term Outcomes


About this study

The purpose of this study is to characterize the various clinical presentations of thrombotic microangiopathies for patients treated at Mayo Clinic, Rochester, MN as well as to characterize the long-term clinical outcomes including frequency of TMA relapses and management approach. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients with a diagnosis of Thrombotic Microangiopathy diagnosed during the years of 1970-2017. 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Ronald Go, M.D.

Closed for enrollment

Contact information:

Ronald Go M.D.


More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer